-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Roth Capital Forecasts Reduced Earnings for Nuvectis Pharma
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) – Research analysts at Roth Capital dropped their Q1 2025 EPS estimates for shares of Nuvectis Pharma in a report issued on Tuesday, February 25th. Roth Capital analyst J. Aschoff now expects that the company will post earnings per share of ($0.28) for the quarter, down from their […]
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) – Research analysts at Roth Capital dropped their Q1 2025 EPS estimates for shares of Nuvectis Pharma in a report issued on Tuesday, February 25th. Roth Capital analyst J. Aschoff now expects that the company will post earnings per share of ($0.28) for the quarter, down from their […]
-logo-1200x675.png&w=240&h=240&zc=2){kind=logo}